American Journal of Kidney Diseases
Volume 56, Issue 1 , Pages 168-174 , July 2010

Severe Hypomagnesemia During Long-term Treatment With a Proton Pump Inhibitor

Received 7 September 2009 ,Accepted 1 March 2010.

References 

  1. Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord. 2003;4(2):195–206
  2. Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med. 2005;20(1):3–17
  3. Wong ET, Rude RK, Singer FR, et al. A high prevalence of hypomagnesemia in hospitalized patients. Am J Clin Pathol. 1983;79(3):348–352
  4. Desai TK, Carlson RW, Geheb MA, et al. Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting. Am J Med. 1988;84(2):209–214
  5. Chernow B, Bamberger F, Stoiko M, et al. Hypomagnesemia in patients in postoperative intensive care. Chest. 1989;95(2):391–397
  6. Fiaccadori E, Del Canale S, Coffrini E, et al. Muscle and serum magnesium in pulmonary intensive care unit patients. Crit Care Med. 1988;16(8):751–760
  7. Kraft MD, Btaiche IF, Sachs GS. Review of the refeeding syndrome. Nutr Clin Pract. 2005;20(6):625–633
  8. Subbiah V, Tayek JA. Tetany secondary to the use of a proton-pump inhibitor. Ann Intern Med. 2002;137(3):219
  9. Epstein M, McGrath S, Law F. Proton pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med. 2006;355(17):1834–1836
  10. Cundy T, Dissanayake A. Severe hypomagnaesemia in long-term users of proton-pump inhibitors. Clin Endocrinol. 2008;69(2):338–341
  11. Shabajee N, Lamb EJ, Sturgess I, Sumathipala RW. Omeprazole and refractory hypomagnesemia. BMJ. 2008;337:a425
  12. Kuipers MT, Thang HD, Arntzhenius AB. Hypomagnesemia due to use of proton pump inhibitors—a review. Neth J Med. 2009;67(5):169–172
  13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130(6):461–470
  14. Rude RK, Bethune JE, Singer FR. Renal tubular maximum for magnesium in normal, hyperparathyroid, and hypoparathyroid man. J Clin Endocrinol Metab. 1980;51(6):1425–1431
  15. Noronha JL, Matuschak GM. Magnesium in critical illness: metabolism, assessment and treatment. Intensive Care Med. 2002;28(6):667–679
  16. Agus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999;10(7):1616–1622
  17. Alexander RT, Hoenderop JGJ, Bindels RJM. Molecular mechanisms of magnesium homeostasis: insights from human disease. J Am Soc Nephrol. 2008;19(8):1451–1458
  18. Quamme GA. Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol. 2008;24(2):230–235
  19. Gunzel D, Yu ASL. Function and regulation of claudins in the thick ascending limb of Henle. Eur J Physiol. 2009;458(1):77–88
  20. Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DEC, Quamme GA. Magnesium transport in the distal convoluted tubule. Physiol Rev. 2001;81(1):51–84
  21. Cao G, Hoenderop JGJ, Bindels RJM. Insights into the molecular regulation of the epithelial magnesium channel TRPM6. Curr Opin Nephrol Hypertens. 2008;17(4):373–378
  22. Rondon LJ, Groenestege WMT, Rayssiguier Y, Mazur A. Relationship between low magnesium status and TRPM6 expression in the kidney and large intestine. Am J Physiol Regul Comp Physiol. 2008;294(6):R2001–R2007
  23. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007;2(2):366–373
  24. Weber S, Hoffmann K, Jeck N, et al. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet. 2000;8(6):414–422
  25. Konrad M, Schaller A, Seelow D, et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet. 2006;79(5):949–957
  26. Schlingmann KP, Weber S, Peters M, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet. 2002;31(2):166–170
  27. Meij IC, Koenderink JB, van Bokhoven H, et al. Dominant isolated renal magnesium loss is caused by misrouting of the Na+,K(+)-ATPase gamma-subunit. Nat Genet. 2000;26(3):265–266
  28. Groenestege WM, Thebault S, van der Wijst J, et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest. 2007;117(8):2260–2267
  29. Simon DB, Karet FE, Hamdan JM, Di Pietro A, Sanjad SA, Lifton RP. Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet. 1996;13(2):183–188
  30. Peters M, Jeck N, Reinalter S, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med. 2002;112(3):183–190
  31. Simon DB, Bindra RS, Mansfield TA, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet. 1997;17(2):171–178
  32. Birkenhager R, Otto E, Schurmann MJ, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet. 2001;29(3):310–314
  33. Schlingmann KP, Konrad M, Jeck N, et al. Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med. 2004;350(13):1314–1319
  34. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12(1):24–30
  35. Watanabe S, Fukumoto S, Chang H, et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet. 2002;360(9334):692–694
  36. Scholl UI, Choi M, Liu T, et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci U S A. 2009;106(14):5842–5847
  37. Bockenhauer D, Feather S, Stanescu HC, et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med. 2009;360(19):1960–1970
  38. Glaudemans B, van derWijst J, Scola RH, et al. A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia. J Clin Invest. 2009;119(4):936–942
  39. Wilson FH, Hariri A, Farhi A, et al. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science. 2004;306(5699):1190–1194
  40. Rude RK, Oldham SB, Singer FR. Functional hypoparathyroidism and parathyroid hormone and organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf). 1976;5(3):209–224
  41. Estep H, Shaw WA, Watlington C, Hobe R, Holland W, Tucker SG. Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness. J Clin Endocrinol Metab. 1969;29(6):842–848
  42. Jeppesen PB, Staun M, Tjellesen L, Mortensen PB. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium and macronutrients in patients with intestinal resection. Gut. 1998;43(6):763–769
  43. Serfaty-Lacrosniere C, Wood RJ, Voytko D, et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr. 1995;14(4):364–368
  44. Dyckner T, Wester PO. Intracellular magnesium loss after diuretic administration. Drugs. 1984;28(suppl 1):161–166

 Originally published online as doi:10.1053/j.ajkd.2010.03.013 on May 21, 2010.

PII: S0272-6386(10)00687-6

doi: 10.1053/j.ajkd.2010.03.013

American Journal of Kidney Diseases
Volume 56, Issue 1 , Pages 168-174 , July 2010

Article Tools

* Image Usage & Resolution